Início

5 | Ensaios Clínicos/Estudos Observacionais

Promotor	Serviço	Investigador Principal	Ensaio
BAYER	MEDICINA INTERNA	Drª Maria João Baldo	FINEARTS – A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants.
ABBVIE	REUMATOLOGIA MEDICINA INTERNA	Drª Claúdia Vaz	M16-852 – A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis.
INSMED	PNEUMOLOGIA	Drª Alcina Tavares	ASPEN – A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis.
SANOFI	PNEUMOLOGIA	Dr. José Manuel Silva	AERIFY – Randomized, doub le-blind, placebo-controlled, parallelgroup Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
NOVO NORDISK	MEDICINA INTERNA	Dr. Adriano Cardoso	ESSENCE – The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis
POLYPID	CIRURGIA	Prof. Doutor Augusto Lourenço	D-PLEX – Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two‐arm, Double Blind Study to Assess Efficacy and Safety of D‐PLEX Administered Concomitantly with the Standard of Care (SoC), Compared to a SoC Treated Control Arm, in Prevention of Post Abdominal Surgery Incisional Infection.
JANSSEN	UNIDADE ONCOLOGIA	Drª Inês Sequeira	CAPA – Characterization of Castrate-Resistant Prostate Cancer patients followed in Urology Department of Portuguese hospitals.
PFIZER	INFECIOLOGIA	Drª Catarina Quinaz	OZAVIE – A prospective, multicentre, observational study in hospitalized patients suffering from infections and treated with ZAVICEFTA® (ceftazidime/avibactam) under actual conditions of use.
GILEAD	UNIDADE ONCOLOGIA	Drª Inês Sequeira	TROPICS – A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer.
ASTRAZENECA	PNEUMOLOGIA	Dr. José Manuel Silva	LOGOS – A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort® Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma.
GSK	PNEUMOLOGIA	Dr. José Manuel Silva	SWIFT – A 52-week, andomized, double-blind, placebo-controlled, parallelgroup, multi-centre study of the efficacy and safety of GSK3511294 adjunctive therapy in adult and adolescent participants with severe uncontrolled asthma with an eosinophilic phenotype.
GSK	PNEUMOLOGIA	Dr. José Manuel Silva	NIMBLE – A 52-week, Randomized, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 compared with mepolizumab or benralizumab.
SEAGEN	ONCOLOGIA	Drª Inês Sequeira	MOUNTAINER – An Open-label Randomized Phase 3 Study of Tucatinib in Combination with Trastuzamab and mFOLFOX6 given with or without either Cetuximab or Bevacizumab as First-line Treatment for Subjects with HER2+ Metastatic Colorectal Cancer.
NOVARTIS	REUMATOLOGIA	Drª Cláudia Vaz	NEPTUNUS: A randomized, double-blind, placebo controlled, 2-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren’s syndrome.

Partilhar: